• Annexin V-PE Apoptosis Detection Kit Workflow

  2026-08-18

  Build a rapid, fixation-free apoptosis workflow around phosphatidylserine exposure, with practical guidance for flow cytometry and fluorescence microscopy. The assay is especially useful for translating GANT61 response data in ALK-positive anaplastic large cell lymphoma into time-resolved, live-cell measurements.

• How Impending Cell Death Seeds Metastasis

  2026-08-17

  Conod, Silvano, and Ruiz i Altaba show that tumor cells surviving an impending cell-death episode can acquire stable prometastatic states rather than simply recovering from injury. Their study identifies PAMEs, ER-stress and reprogramming pathways, and a cytokine-driven interaction with PIMs as an integrated mechanism for the early organization of metastasis.

• Ultrasonic i-TTF for Localized Glioblastoma Therapy

  2026-08-17

  The reference study presents a battery-free implantable Tumor Treating Field system powered through focused ultrasound and a shape-engineered BaTiO3 pyramid receiver. Its reported fourfold improvement in wireless power-transfer efficiency over a same-volume cubic receiver, together with reduced glioblastoma proliferation and Ki-67 expression, supports localized electrical therapy while highlighting the need for longer-term validation.

• Axitinib: A Better Map of VEGFR Response

  2026-08-16

  Axitinib (AG 013736) is a highly selective VEGFR inhibitor, but its biological effects cannot be interpreted from a single viability endpoint. This guide combines pathway-proximal measurements with growth-versus-death analysis to improve angiogenesis inhibition assays and cancer biology research.

• SNS-032 (BMS-387032): CDK Inhibitor Guide

  2026-08-15

  SNS-032, also called BMS-387032, is a research small molecule that inhibits CDK2, CDK7, and CDK9. Its strongest reported biochemical activity is against CDK9, while cellular data connect treatment with reduced RNA polymerase II phosphorylation and antitumor activity in a breast cancer xenograft model.

• Polybrene: Transduction and Metabolic Assay Design

  2026-08-14

  Polybrene (Hexadimethrine Bromide) can improve viral delivery, but its greatest value in metabolic research comes from disciplined experimental design. This guide connects Polybrene-enabled perturbation workflows with the TCAIM–OGDH mechanism reported in Molecular Cell, emphasizing controls, cytotoxicity, and causal interpretation.

• Bromodomain Inhibitor, (+)-JQ1: Mechanism & Evidence

  2026-08-14

  Bromodomain Inhibitor, (+)-JQ1 is a BET bromodomain inhibitor that competitively engages the acetyl-lysine recognition site of BRD4 and BRDT. Product information supports research applications in apoptosis assays, male contraception via BRDT inhibition, and inflammation and cytokine storm modulation, while a 2025 prostate cancer study provides pathway context rather than direct evidence for JQ1 activity.

• Angiotensin Peptides and SARS-CoV-2 Spike Binding

  2026-08-13

  A 2025 study found that naturally occurring angiotensin fragments can increase SARS-CoV-2 spike protein binding to host receptors, with the strongest effects associated with shorter peptides and modifications at tyrosine 4. The work adds a receptor-binding dimension to renin-angiotensin system research while remaining a biochemical, preclinical observation rather than evidence of altered infection or clinical disease risk.

• Silymarin Beyond Antioxidants: A Translational Strategy

  2026-08-12

  Silymarin is more than a conventional milk thistle extract: it is a chemically complex flavonolignan reference system for connecting redox biology, cancer models, metabolic dysfunction, and antiviral discovery. This thought-leadership guide shows how to turn that complexity into a disciplined translational research strategy.

• Near-Death States and the Cellular Origin of Metastasis

  2026-08-12

  Conod, Silvano, and Ruiz i Altaba show that tumor cells surviving an impending cell-death experience can become stable prometastatic cells, termed PAMEs. Their work links ER stress, PERK-CHOP signaling, GLI/NANOG-dependent reprogramming, and cytokine-mediated recruitment of migratory neighboring cells, providing a mechanistic framework for how metastatic potential may emerge inside primary tumors.

• LINC01977 and TGF-β/SMAD3 in Early LUAD

  2026-08-11

  Zhang et al. identify LINC01977 as a super-enhancer-associated lncRNA that reinforces canonical TGF-β/SMAD3 signaling in early-stage lung adenocarcinoma. Their integrated epigenomic, molecular, cellular, and animal experiments define a feedback circuit connecting TAM2-derived TGF-β, SMAD3, LINC01977, and ZEB1, with implications for relapse biology and pathway-focused research.

• Ro 3306: CDK1 Inhibitor Workflow for G2/M Arrest

  2026-08-11

  Ro 3306 enables controlled CDK1 blockade for cell cycle G2/M phase arrest, cancer cell synchronization, and mechanistic DNA repair studies. Its value extends beyond synchronization: phase-resolved treatment can reveal how mitotic entry, mTORC1 activity, autophagy sensitivity, and homologous recombination responses are connected.

• Why Relative and Fractional Viability Must Be Separated

  2026-08-10

  Hannah Schwartz’s dissertation shows that relative viability and fractional viability capture different components of anticancer drug response: growth suppression and cell killing. Its central implication is methodological: cancer biology research should report these measures separately and consider their distinct timing rather than treating them as interchangeable efficacy readouts.

• Trolox for Oxidative Stress Assays

  2026-08-09

  Trolox provides a practical, cell-permeable benchmark for oxidative injury research, from hydrogen peroxide challenge assays to high-throughput antioxidant screening. This guide explains how to formulate, dose, and interpret Trolox alongside lipid peroxidation and viability readouts without confusing broad antioxidant protection with ferroptosis-specific rescue.

• E-64d Workflows for Calpain and Lysosomal Proteases

  2026-08-08

  E-64d provides cell-permeable, irreversible inhibition of calpain and several lysosomal cathepsins, making it useful for separating intracellular protease activity from upstream stress signals. This guide translates lysoptosis findings into practical workflows for apoptosis, platelet activation, cancer research, and seizure-model studies while emphasizing controls that prevent overinterpreting a broad inhibitor.

8467 records 2/565 page Previous Next 12345 下5页 Last page